Real‐world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single‐center with homogeneous treatment experience-Reference-Cited by-同舟云学术

Real‐world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single‐center with homogeneous treatment experience

Published:2022-09-24 Issue:11 Volume:62 Page:2363-2369
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Jiménez Moraima¹²^ORCID,Bobillo Sabela¹²,Pons Verónica³,Sánchez Carla¹,Pérez Ana¹²,Molero Antonieta¹²,Miranda Nayibe¹,Sánchez Ángela¹,Tabares Elizabeth¹,Bosch Francesc¹²,Valcárcel David¹²

Affiliation:

1. Servei d'Hematologia, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain

2. Department of Medicine Universitat Autònoma de Barcelona Barcelona Spain

3. Banc de Sang y Teixits Vall d'Hebron Barcelona Hospital Campus Barcelona Spain

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.17111

Reference13 articles.

1. Thrombotic thrombocytopenic purpura

2. Pathophysiology of thrombotic thrombocytopenic purpura

3. Thrombotic thrombocytopenic purpura